Published in J Hyg (Lond) on October 01, 1975
Experimental model of oral antityphoid vaccination with live streptomycin-dependent Salmonella typhimurium in C57BL/6 mice. J Hyg (Lond) (1975) 0.76
Production and characterization of streptomycin dependent mutants of Pasteurella multocida from bovine haemorrhagic septicaemia. Can J Comp Med (1980) 0.75
Mechanisms of acquired resistance in mouse typhoid. J Exp Med (1966) 9.20
Observations on Bacteria Sensitive to, Resistant to, and Dependent upon Streptomycin. J Bacteriol (1948) 7.56
ABORTIVE INTESTINAL INFECTION WITH AN ESCHERICHIA COLI-SHIGELLA FLEXNERI HYBRID STRAIN. J Bacteriol (1965) 6.84
Typhoid fever: pathogenesis and immunologic control. N Engl J Med (1970) 4.95
Studies on vaccination against bacillary dysentery. 2. Safety tests and reactogenicity studies on a live dysentery vaccine intended for use in field trials. Bull World Health Organ (1965) 4.57
Studies on vaccination against bacillary dysentery. 3. Effective oral immunization against Shigella flexneri 2a in a field trial. Bull World Health Organ (1965) 4.37
Transduction of virulence within the species Salmonella typhimurium. J Gen Microbiol (1956) 4.05
Studies on vaccination against bacillary dysentery. 1. Immunization of mice against experimental Shigella infection. Bull World Health Organ (1965) 3.97
Resistance to reinfection in experimental mouse typhoid. J Hyg (Lond) (1957) 3.95
The effects of biochemical mutation on the virulence of Bacterium typhosum; the loss of virulence of certain mutants. Br J Exp Pathol (1951) 3.92
Protection of Monkeys Against Experimental Shigellosis with Attenuated Vaccines. J Bacteriol (1965) 2.93
Studies on vaccination against bacillary dysentery. 4. Oral immunization with live monotypic and combined vaccines. Bull World Health Organ (1968) 2.68
The preparation, testing and standardization of typhoid vaccine. J Hyg (Lond) (1952) 2.59
Protection of monkeys against experimental shigellosis with a living attenuated oral polyvalent dysentery vaccine. J Bacteriol (1966) 2.23
Streptomycin Resistance in Escherichia Coli Analyzed by Transduction. Genetics (1960) 1.89
Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains. Bull World Health Organ (1971) 1.84
Immunity in typhoid fever: evaluation of live streptomycin-dependent vaccine. Antimicrob Agents Chemother (Bethesda) (1970) 1.82
Early antibody response in mice to either infection or immunization with Salmonella typhimurium. J Bacteriol (1967) 1.63
Oral Immunization in Experimental Salmonellosis III. Behavior of Virulent and Temperature-Sensitive Mutant Strains in the Intestinal Tissues of Rats. Infect Immun (1970) 1.34
Oral immunization against experimental salmonellosis I. Development of temperature-sensitive mutant vaccines. Infect Immun (1970) 1.23
Effects of modified host metabolism and altered defense mechanisms on survival time and pathogen counts in tissues and total body of mice infected intravenously with Salmonella typhimurium. J Infect Dis (1958) 1.23
Infectivity and antigenicity of streptomycin-dependent Salmonella typhosa. J Infect Dis (1967) 1.19
Genetic analyses of mutations from streptomycin dependence to independence in Salmonella typhimurium. Genetics (1962) 1.06
Oral Immunization in Experimental Salmonellosis II. Characteristics of the Immune Response to Temperature-Sensitive Mutants Given by Oral and Parenteral Routes. Infect Immun (1970) 1.03
Immunization studies with living vaccine of Salmonella typhimurium. Proc Soc Exp Biol Med (1961) 1.01
A quantitative comparison of the antigenic structure of a virulent and an avirulent strain of Salmonella typhimurium. Immunology (1969) 1.01
Study of live typhoid vaccine in chimpanzees. Bull World Health Organ (1970) 0.98
LABORATORY TESTS ON THE EFFECTIVENESS OF ORAL VACCINATION OF YOUNG CHILDREN AGAINST TYPHOID AND PARATYPHOID A AND B. Bull World Health Organ (1965) 0.93
[LIVE VACCINE IMMUNIZATION IN EXPERIMENTAL TYPHOID WITH A STREPTOMYCIN DEPENDENT STRAIN OF SALMONELLA ENTERITIDIS]. Nihon Saikingaku Zasshi (1965) 0.81
[Behavior of DBA and H mice toward experimental infection with S. typhimurium]. Arch Roum Pathol Exp Microbiol (1964) 0.78
[Genetic stability of the non-pathogenic and anti-infectious immunogenic character of some strains of Sh. flexneri 2a]. Arch Roum Pathol Exp Microbiol (1965) 0.77
Treatment of dysentery bacilli carriers with a live nonpathogenic antidysenteric vaccine. Arch Immunol Ther Exp (Warsz) (1968) 0.77
[CONTRIBUTION TO THE STUDY OF ORAL ANTI-TYPHOID VACCINATION]. Microbiol Parazitol Epidemiol (Bucur) (1965) 0.77
Contributions to the study of Salmonella. Immunological specificity of proteins separated from Salmonella typhi. Immunology (1966) 1.62
The fecal microbial population in the irritable bowel syndrome. Microbiologica (1982) 1.40
Development of resistance during ceftazidime and cefepime therapy in a murine peritonitis model. J Antimicrob Chemother (1992) 1.08
Fish oil decreases natural resistance of mice to infection with Salmonella typhimurium. Metabolism (1992) 0.95
Effects of ampicillin, ceftriaxone, chloramphenicol, pefloxacin and trimethoprim-sulphamethoxazole on Salmonella typhi within human monocyte-derived macrophages. J Antimicrob Chemother (1990) 0.89
Helicobacter pylori: cultivability and antibiotic susceptibility of coccoid forms. Int J Antimicrob Agents (2000) 0.85
Helicobacter pylori: ureA, cagA and vacA expression during conversion to the coccoid form. Int J Antimicrob Agents (2000) 0.83
Listeria monocytogenes infections: the organism, its pathogenicity and antimicrobial drugs susceptibility. New Microbiol (1993) 0.83
Influence of amoxicillin, erythromycin and metronidazole on adherence of Helicobacter pylori. New Microbiol (1995) 0.82
Activity of amoxicillin, metronidazole, bismuth salicylate and six aminoglycosides against Helicobacter pylori. J Chemother (1996) 0.80
Fish oil enhances macrophage tumor necrosis factor-alpha mRNA expression at the transcriptional level. Metabolism (1995) 0.78
[Antimicrobial activity of nifuratel]. G Ital Chemioter (1986) 0.78
Anti-Helicobacter pylori agents endowed with H2-antagonist properties. Bioorg Med Chem Lett (2001) 0.76
Experimental model of oral antityphoid vaccination with live streptomycin-dependent Salmonella typhimurium in C57BL/6 mice. J Hyg (Lond) (1975) 0.76
Activity of calvatic acid and its analogs against Helicobacter pylori. Pharmazie (2001) 0.76
[Midecamycin activity against aerobic and anaerobic bacteria]. G Ital Chemioter (1986) 0.75
[Tissue distribution of carbon-14 following oral administration of 14C-arginine thiazolidinecarboxylate in rats]. Farmaco Prat (1981) 0.75
[Action of daunomycin on oxygen consumption by various tissues (hepatic and cerebral tissues and cells of the Ehrlich ascites carcinoma)]. Arch Ital Patol Clin Tumori (1972) 0.75
[Lactulose: pharmacodynamic evaluation]. Boll Chim Farm (1976) 0.75
[Research on erythromycin and spiramycin in saliva]. Dent Cadmos (1976) 0.75
Arginine thiazolidinecarboxylate 14C uptake by individual phospholipids isolated from rat liver microsomes. Int J Clin Pharmacol Ther Toxicol (1981) 0.75
[Transmethylating activity of arginine thiazolidinecarboxylate (ATCA) in acute CCL4 poisoning and diet-induced steatosis in the rat]. Farmaco Prat (1980) 0.75
[Bacteria and infections of the genitourinary system]. Minerva Urol Nefrol (1989) 0.75
[Complex experimental study on anti-Salmonella typhi vaccination. Protective property of human and rabbit serums for the mouse and chick embryo]. Ann Inst Pasteur (Paris) (1971) 0.75
[Experimental cystitis in the rat and the therapeutic effect of a single dose of fosfomycin trometamol]. Ann Ist Super Sanita (1987) 0.75
Mutagenicity studies on tiopronin. Arzneimittelforschung (1986) 0.75
[Inhibition of the mitotic activity of human leukocytes in vitro by 3'-5'-AMP]. Arch Ital Patol Clin Tumori (1971) 0.75
Antibacterial activity and pharmacokinetics in mice of two new derivatives of norfloxacin. Chemioterapia (1987) 0.75
[Thymolytic activity of chlorimipramine]. Minerva Med (1975) 0.75
[Potentiation of the antiviral activity of daunomycin by desmethylimipramine]. Minerva Med (1975) 0.75
'In vitro' development of metronidazole, erythromycin, amoxicillin and gentamicin resistance in Helicobacter pylori. Int J Antimicrob Agents (1996) 0.75
[Contribution to the immunochemical study of Salmonella. Preservation of antigens in acetoned bacteria. Method of extraction preserving the flagellar antigens]. Rev Immunol Ther Antimicrob (1966) 0.75
Rumanian contributions to the study of per oral antityphoid vaccination. Rum Med Rev (1966) 0.75
[Lactulose: toxicological evaluation]. Boll Chim Farm (1976) 0.75
[Potentiation of the anti-tumor activity of daunomycin by chloroimipramine]. Arch Ital Patol Clin Tumori (1972) 0.75
Microbiological evaluation of cefoperazone, a new semisynthetic cephalosporin. Clin Ther (1980) 0.75
Antifungal activity of two benzofuran-imidazoles in different experimental conditions. J Chemother (1991) 0.75
Mutagenicity studies on PTT-119. Farmaco Prat (1987) 0.75
[Profile of resistance to antibiotics in Salmonella isolated from a Milanese population in 1981]. G Ital Chemioter (1983) 0.75
[Normalizing effect of arginine thiazolidincarboxylate (ATCA) on hepatocytes in CCL4 poisoning in rats]. Farmaco Prat (1980) 0.75
[Chloroimipramine, in association with dibutyryl cyclic 3'-5' AMP , increases its stimulating effect on growth of the Ehrlich ascites carcinoma]. Arch Ital Patol Clin Tumori (1972) 0.75
[Antimitotic activity of lithium chloride on human leukocytes in culture]. Arch Ital Patol Clin Tumori (1970) 0.75
[Antimitotic activity of formicin, ketocaine and chloroimipramine on human leukocytes in culture stimulated with phytohemagglutinin]. Arch Ital Patol Clin Tumori (1972) 0.75
In-vitro antibacterial activity of Sch 25393, a fluorinated analogue of thiamphenicol. J Antimicrob Chemother (1984) 0.75
[Antimitotic activity of some derivatives of imipramine]. Minerva Med (1975) 0.75
[Effect of oral inoculation with live streptomycin-dependent S. typhimurium in C57BL/6 mice]. J Biol Stand (1978) 0.75
[Synthesis and microbiologic activity of a new class of imidazole derivatives]. Farmaco Sci (1986) 0.75
[Bone marrow cryptococcosis as the first manifestation of AIDS]. Pathologica (1993) 0.75
[Determination of the proteolytic activity of pancreatin and pancreatin containing drugs]. Boll Chim Farm (1966) 0.75
[Activity of topical flunoxaprofen in nonspecific vaginitis. Comparison with meclocycline sulfosalicylate]. Minerva Ginecol (1989) 0.75
[Protective effect of arginine thiazolidinecarboxylate on morphological and functional changes in the liver induced by chronic ethanol intoxication in the rat]. Farmaco Prat (1980) 0.75